Diphenylcyclopropenone (DPCP), Upadacitinib (RINVOQ), Dupilumab (DUPIXENT) clinical trials

An experimental study to assess a diphenylcyclopropenone skin challenge model in healthy participants for the evaluation of immunomodulatory therapies

This study tests a mild skin irritation method to understand how the immune system works. We're looking for healthy adults, aged 18-55, to participate. The goal is to find new ways to test medicines for conditions like autoimmune diseases and cancer without always needing sick patients.